Description
Emgality (galcanezumab) is a humanized monoclonal antibody that binds to CGRP for the preventive treatment of migraine and episodic cluster headache.
$1,874.16
CGRP monoclonal antibody for migraine
Emgality (galcanezumab) is a humanized monoclonal antibody that binds to CGRP for the preventive treatment of migraine and episodic cluster headache.
Reviews
There are no reviews yet.